Aizon closes $20M Series C to boost operations and headcount

An AI provider that caters to biopharma manufacturers has closed a $20 million Series C raise to expand its operations and bring its third tech product to commercialization. Notably, the fund will increase its staff numbers by 20% to around 100 employees.

Launched in 2014, San Francisco-based Aizon’s technology captures…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks